Abortion drug could reduce risk of aggressive cancer

15 June 2022

The drug Mifepristone, which is currently used for medical abortions, could reduce the risk of triple negative breast cancer in women with an alteration of the BRCA1 gene, finds a new study led by Professor Martin Widschwendter (UCL EGA Institute for Women’s Health).